Share

Pfizer earnings higher on vaccine sales

New York - US pharmaceutical giant Pfizer Tuesday reported slightly higher quarterly earnings as stronger sales in vaccines and some other products offset the negative hit from patent expirations on other medications.

Earnings for the third quarter came in at $2.7bn, up 2.9% from the year-ago period on slightly lower total sales.

Revenues in some segments fell due to generic competition for several leading drugs, including the sexual dysfunction medication Viagra and the incontinence drug Detrol.

But Pfizer notched a 19% rise in global vaccines revenues, thanks in part to the surge in use of Prevnar, whose uses include prevention of pneumonia in seniors.

Pfizer also cited sales of nerve pain drug Lyrica as a bright spot.

"Overall, I am pleased with our third-quarter 2014 financial results despite the continued negative impact from product losses of exclusivity and the termination of certain co-promotion collaborations," said chief financial officer Frank D'Amelio.

Pfizer said it continued to expect $5bn in share repurchases in 2014. Its news release did not mention its unsuccessful effort to acquire AstraZeneca after the British company refused to engage in talks.

Pfizer lowered its forecast for adjusted full-year sales from $48.7bn to $50.7bn to $48.7bn to $49.7bn.

Pfizer's third-quarter results translated into adjusted earnings of 57 cents per share, two cents above analyst estimates.

Revenues were down 2.2% to $12.36bn, above the $12.22bn analyst forecast.

Pfizer shares rose 1.7% to $29.60 in pre-market trade.

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Rand - Dollar
18.94
-0.2%
Rand - Pound
23.91
-0.1%
Rand - Euro
20.43
+0.2%
Rand - Aus dollar
12.34
+0.1%
Rand - Yen
0.13
-0.2%
Platinum
910.50
+1.5%
Palladium
1,011.50
+1.0%
Gold
2,221.35
+1.2%
Silver
24.87
+0.9%
Brent Crude
86.09
-0.2%
Top 40
68,346
+1.0%
All Share
74,536
+0.8%
Resource 10
57,251
+2.8%
Industrial 25
103,936
+0.6%
Financial 15
16,502
-0.1%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders